1
|
Abbas SR, Khan RT, Shafique S, Mumtaz S, Khan AA, Khan AM, Hassan Z, Hussain SA, Abbas S, Abbas MR, Batool A, Safder MA. Study of resveratrol against bone loss by using in-silico and in-vitro methods. BRAZ J BIOL 2021; 83:e248024. [PMID: 34932613 DOI: 10.1590/1519-6984.248024] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Accepted: 05/29/2021] [Indexed: 11/22/2022] Open
Abstract
By applying the in-silico method, resveratrol was docked on those proteins which are responsible for bone loss. The Molecular docking data between the resveratrol and Receptor activator of nuclear factor-kappa-Β ligand [RANKL] receptors proved that resveratrol binds tightly to the receptors, showed the highest binding affinities of -6.9, -7.6, -7.1, -6.9, -6.7, and -7.1 kcal/mol. According to in-vitro data, Resveratrol reduced the osteoclasts after treating Marrow-Derived Macrophages [BMM] with Macrophage colony-stimulating factor [MCSF] 20ng / ml and RANKL 50ng / ml, with different concentrations of resveratrol (2.5, 10 μg / ml) For 7 days, the cells were treated with MCSF (20 ng / ml) and RANKL (40 ng / ml) together with concentrated trimethyl ether and resveratrol (2.5, 10 μg / ml) within 12 hours. Which, not affect cell survival. After fixing osteoclast cells with formaldehyde fixative on glass coverslip followed by incubation with 0.1% Triton X-100 in PBS for 5 min and after that stain with rhodamine phalloidin staining for actin and Hoechst for nuclei. Fluorescence microscopy was performed to see the distribution of filaments actin [F.actin]. Finally, resveratrol reduced the actin ring formation. Resveratrol is the best bioactive compound for drug preparation against bone loss.
Collapse
Affiliation(s)
- S R Abbas
- Karakoram International University, Department of Biological Sciences, Gilgit, Pakistan
| | - R T Khan
- University of Azad Jammu and Kashmir, Department of Botany, Azad Jammu and Kashmir, Pakistan
| | - S Shafique
- University of Poonch, Department of Plant Breeding and Molecular Genetics, Rawalakot, Azad Jammu and Kashmir, Pakistan
| | - S Mumtaz
- Karakoram International University, Department of Biological Sciences, Gilgit, Pakistan
| | - A A Khan
- Bahauddin Zakariya University, College of Agriculture Bahadur Campus, Layyah, Pakistan
| | - A M Khan
- University of Sargodha, Department of Biotechnology, Sargodha, Pakistan
| | - Z Hassan
- Bahauddin Zakariya University, College of Agriculture Bahadur Campus, Layyah, Pakistan
| | - S A Hussain
- Karakoram International University, Department of Biological Sciences, Gilgit, Pakistan
| | - S Abbas
- Karakoram International University, Department of Biological Sciences, Gilgit, Pakistan
| | - M R Abbas
- University of Azad Jammu and Kashmir, Department of Computer Sciences and IT, Muzaffarabad, Pakistan
| | - A Batool
- Virtual University Lahore, Department of Biotechnology, Lahore, Pakistan
| | - M A Safder
- Karakoram International University, Department of Biological Sciences, Gilgit, Pakistan
| |
Collapse
|
2
|
Ke K, Safder MA, Sul OJ, Kim WK, Suh JH, Joe Y, Chung HT, Choi HS. Hemeoxygenase-1 maintains bone mass via attenuating a redox imbalance in osteoclast. Mol Cell Endocrinol 2015; 409:11-20. [PMID: 25841764 DOI: 10.1016/j.mce.2015.03.022] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2015] [Revised: 03/25/2015] [Accepted: 03/29/2015] [Indexed: 01/28/2023]
Abstract
Heme oxygenase-1 (HO-1) has long been considered to be an endogenous antioxidant. However, the role of HO-1 is highly controversial in developing metabolic diseases. We hypothesized that HO-1 plays a role in maintaining bone mass by alleviating a redox imbalance. We investigated its role in bone remodeling. The absence of HO-1 in mice led to decreased bone mass with elevated activity and number of OCs, as well as higher serum levels of reactive oxygen species (ROS). HO-1, which is constitutively expressed at a high level in osteoclast (OC) precursors, was down-regulated during OC differentiation. HO-1 deficiency in bone marrow macrophages (BMM) in vitro resulted in increased numbers and activity of OCs due to enhanced receptor activator of nuclear factor-κB ligand (RANKL) signaling. This was associated with increased activation of nuclear factor-κB and of nuclear factor of activated T-cells, cytoplasmic 1 along with elevated levels of intracellular calcium and ROS. Decreased bone mass in the absence of HO-1 appears to be mainly due to increased osteoclastogenesis and bone resorption resulting from elevated RANKL signaling in OCs. Our data highlight the potential role of HO-1 in maintaining bone mass by negatively regulating OCs.
Collapse
Affiliation(s)
- Ke Ke
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - M A Safder
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - Ok-Joo Sul
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - Woon-Ki Kim
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - Jae-Hee Suh
- Department of Pathology, Ulsan University Hospital, Ulsan 682-714, Republic of Korea
| | - Yeonsoo Joe
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - Hun-Taeg Chung
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
| | - Hye-Seon Choi
- Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea.
| |
Collapse
|